Verlag: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: California Books, Miami, FL, USA
Zustand: New.
Verlag: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 41,78
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Verlag: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: Books Puddle, New York, NY, USA
Zustand: New.
Verlag: LAP LAMBERT Academic Publishing Jan 2025, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. Neuware -AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error.Books on Demand GmbH, Überseering 33, 22297 Hamburg 60 pp. Englisch.
Verlag: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. AI and Machine Learning in Radiopharmaceutical Development | "From Design to Therapy: The Impact of AI in Radiopharmaceutical Development" | Khushboo Gupta (u. a.) | Taschenbuch | Englisch | 2025 | LAP LAMBERT Academic Publishing | EAN 9786208418274 | Verantwortliche Person für die EU: LAP Lambert Academic Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.
Verlag: KS Omniscriptum Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Verlag: KS Omniscriptum Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 44,29
Anzahl: Mehr als 20 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Verlag: LAP LAMBERT Academic Publishing Jan 2025, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 60 pp. Englisch.
Verlag: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 64,49
Anzahl: 4 verfügbar
In den WarenkorbZustand: New. Print on Demand.
Verlag: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND.
Verlag: LAP Lambert Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
EUR 49,58
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: new. Paperback. AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Verlag: LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Sprache: Englisch
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error.